Bioprocessing:Article Title: A Novel Signaling Pathway
Article Snippet: .. Antibodies and Reagents Antibodies used in this study and their sources were as follows: rabbit anti-mouse uPA, Molecular Innovations Inc. (Novi, MI); antibodies to nAChRα1, -β1, or -γ and FGF-2, Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); antibodies to uPAR1, phosphotyrosine, and E-cadherin (R&D Systems, Minneapolis, MN); rat monoclonal antibody to F4/80, Serotec Ltd. (Oxford, UK); EPO TM horseradish peroxidase-conjugated monoclonal antibodies to vimentin, αSMA, or PCNA and rat monoclonal antibody to Ki-67 (TEC-3), Dako Corp. (Carpinteria, CA); rabbit monoclonal antibody to Ki-67 (SP6), Novus Biologicals Inc. (Littleton, CO); rabbit antibody to receptor-conjugated choline glutaric acid (receptor-bound acetylcholine), Abcam Inc. (Cambridge, MA); fluorescein isothiocyanate-conjugated antibody to β-actin, Sigma; and rat anti-bromodeoxyuridine (BrdUrd) monoclonal antibody (Harlan SERA-LAB, Loughborough, UK). .. Protein reagents used in the in vitro intervention studies were as follows: active mouse urokinase (uPA) and amino-terminal fragment of mouse uPA (ATF), Molecular Innovations, Inc.; α-bungarotoxin (αBTx), d -tubocurarine ( d -TC), and neonicotine (neoN), Sigma.
Article Title: A Novel Signaling Pathway
Article Snippet: .. Antibodies used in this study and their sources were as follows: rabbit anti-mouse uPA, Molecular Innovations Inc. (Novi, MI); antibodies to nAChRα1, -β1, or -γ and FGF-2, Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); antibodies to uPAR1, phosphotyrosine, and E-cadherin (R&D Systems, Minneapolis, MN); rat monoclonal antibody to F4/80, Serotec Ltd. (Oxford, UK); EPO TM horseradish peroxidase-conjugated monoclonal antibodies to vimentin, αSMA, or PCNA and rat monoclonal antibody to Ki-67 (TEC-3), Dako Corp. (Carpinteria, CA); rabbit monoclonal antibody to Ki-67 (SP6), Novus Biologicals Inc. (Littleton, CO); rabbit antibody to receptor-conjugated choline glutaric acid (receptor-bound acetylcholine), Abcam Inc. (Cambridge, MA); fluorescein isothiocyanate-conjugated antibody to β-actin, Sigma; and rat anti-bromodeoxyuridine (BrdUrd) monoclonal antibody (Harlan SERA-LAB, Loughborough, UK). .. Protein reagents used in the in vitro intervention studies were as follows: active mouse urokinase (uPA) and amino-terminal fragment of mouse uPA (ATF), Molecular Innovations, Inc.; α-bungarotoxin (αBTx), d -tubocurarine ( d -TC), and neonicotine (neoN), Sigma.
Article Title: A Novel Signaling Pathway
Article Snippet: .. Antibodies and Reagents—Antibodies used in this study and their sources were as follows: rabbit anti-mouse uPA, Molecular Innovations Inc. (Novi,MI); antibodies to nAChR 1, - 1, or - and FGF-2, SantaCruzBiotechnology, Inc. (SantaCruz, CA); antibodies to uPAR1, phosphotyrosine, and E-cadherin (R&D Systems,Minneapolis, MN); rat monoclonal antibody to F4/80, Serotec Ltd. (Oxford, UK); EPOTM horseradish peroxidaseconjugated monoclonal antibodies to vimentin, SMA, or PCNA and rat monoclonal antibody to Ki-67 (TEC-3), Dako Corp. (Carpinteria, CA); rabbit monoclonal antibody to Ki-67 (SP6), Novus Biologicals Inc. (Littleton, CO); rabbit antibody to receptor-conjugated choline glutaric acid (receptor-bound acetylcholine), Abcam Inc. (Cambridge, MA); fluorescein isothiocyanate-conjugated antibody to -actin, Sigma; and rat antibromodeoxyuridine (BrdUrd) monoclonal antibody (Harlan SERA-LAB, Loughborough, UK). .. Protein reagents used in the in vitro intervention studies were as follows: active mouse urokinase (uPA) and amino-terminal fragment of mouse uPA (ATF), Molecular Innovations, Inc.; -bungarotoxin ( BTx), D-tubocurarine (d-TC), and neonicotine (neoN), Sigma.
|